3D Cortical Spheroids from hiPSCs for Drug Screening
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current methods for generating human cortical cells, such as neural progenitors and astrocytes, face challenges in replicating the complexity and functionality of the three-dimensional nervous system, including incomplete corticogenesis, limited efficiency, and immaturity of neurons, which hinders drug discovery and disease modeling.
Innovation Solution
The development of a method to generate human cortical spheroids from induced pluripotent stem cells, allowing for the differentiation into neural progenitors, astrocytes, and cortical neurons, which can be used for drug screening and disease modeling, utilizing a feeder-free and xeno-free system that promotes the formation of functional neural networks.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Ease of manufacture
If 2D monolayer methods are used for neural differentiation, then the process is simplified and standardized, but the cytoarchitecture and functionality of neural networks cannot be recapitulated
Solution Approach 1:
The patent transitions from 2D monolayer culture to 3D suspended spheroid culture. This dimensional change enables the formation of three-dimensional cytoarchitecture with proper cortical layering and neuronal organization, while maintaining the standardized protocol benefits through controlled differentiation factors and culture conditions in suspension
2Reliability
If 3D organoid cultures are used to recapitulate corticogenesis, then cytoarchitecture and self-organization are improved, but controlled specification of neural cell types and reproducibility become limited
Solution Approach 1:
The patent optimizes specific culture parameters including suspension culture conditions, differentiation factor concentrations and timing, and culture medium composition. These parameter changes enable consistent reproduction of cortical spheroids with proper cytoarchitecture across different hiPSC lines, balancing biological complexity with experimental reproducibility
3Manufacturing precision
If separate differentiation of neurons and glia is performed, then cell type purity is achieved, but the process becomes laborious and synaptogenesis is incomplete
Solution Approach 1:
The patent merges the differentiation of neurons and astrocytes into a single synchronized protocol from hiPSCs. Both cell types differentiate simultaneously in suspension culture and are co-cultured together, eliminating separate differentiation steps while ensuring proper neuron-glia interactions and complete synaptogenesis
4Reliability
If rodent astrocytes are used for co-culture, then synaptogenesis is supported, but the system becomes xeno-dependent and less physiologically relevant
Solution Approach 1:
The patent develops a universal human-only system where hiPSC-derived human astrocytes support synaptogenesis of hiPSC-derived human neurons. This multi-functional approach replaces rodent astrocytes with human astrocytes that provide the same trophic support while maintaining physiological relevance for human disease modeling and drug screening
Data Source
AI summary
Human pluripotent stem cells are differentiated in vitro into human cortical spheroids (hCS), which contain astrocytes, as well as cortical progenitors and neurons for use in analysis, screening programs, and the like.